Michelle Blouin

A Selective Androgen Receptor Modulator (OPK-88004) in Prostate Cancer Survivors: A Randomized Trial.

A. Kibel, S. Bhasin, D. Berry, 2021, The Journal of clinical endocrinology and metabolism.